【FINTEC 0150 交流专区】（前名 ASIABIO）

icy97

Type	Announcement
Subject	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) FUND RAISING
Description	PROPOSED PRIVATE PLACEMENT
Reference is made to the Company’s announcements dated 8 July 2015, 9 July 2015 and 19 February 2016 in relation to the Proposed Private Placement and announcement dated 17 February 2016 in relation to the Bumiputera equity condition (“Announcements”). Unless otherwise defined, the definitions set out in the Announcements shall apply herein. Please refer to the attachment for the details of the revised utilisation of proceeds. This announcement is dated 11 March 2016.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5027701

Attachments Revised utilisation.pdf

icy97

Type	Announcement
Subject	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) FUND RAISING
Description	PROPOSED PRIVATE PLACEMENT
Reference is made to the Company’s announcements dated 8 July 2015, 9 July 2015, 19 February 2016 and 11 March 2016 in relation to the Proposed Private Placement (“Announcements”). Unless otherwise defined, the definitions set out in the Announcements shall apply herein. On behalf of the Board, TA Securities wishes to provide additional information in relation to the Proposed Private Placement. Please refer to the attachment for further details. This announcement is dated 7 April 2016.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5052749

Attachments Announcement - Further Information.pdf

icy97

Type	Announcement
Subject	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) FUND RAISING
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" OR THE "COMPANY")PRIVATE PLACEMENT OF UP TO TEN PERCENT (10%) OF THE ISSUED AND PAID-UP SHARE CAPITAL OF ABT ("PRIVATE PLACEMENT")
Reference is made to the Company’s announcements dated 8 July 2015, 9 July 2015, 19 February 2016, 11 March 2016, 7 April 2016 and 8 April 2016 in relation to the Private Placement (“Announcements”). Unless otherwise defined, the definitions set out in the Announcements shall apply herein. On behalf of the Board, TA Securities wishes to announce that the Board has on 23 May 2016 fixed the issue price for 86,671,000 Placement Shares at RM0.05 each. This issue price represents a premium of approximately 24.38% to the five (5)-day volume weighted average market price of the ABT Shares up to and including 20 May 2016 of RM0.0402. This announcement is dated 23 May 2016.

icy97

Type	Announcement
Subject	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) FUND RAISING
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" OR THE "COMPANY")PRIVATE PLACEMENT OF UP TO TEN PERCENT (10%) OF THE ISSUED AND PAID-UP SHARE CAPITAL OF ABT ("PRIVATE PLACEMENT")
Reference is made to the Company’s announcements dated 8 July 2015, 9 July 2015, 19 February 2016, 11 March 2016, 7 April 2016, 8 April 2016 and 23 May 2016 in relation to the Private Placement (“Announcements”). Unless otherwise defined, the definitions set out in the Announcements shall apply herein. On 23 May 2016, the Board fixed the issue price for 86,671,000 Placement Shares at RM0.05 each. Pursuant to Rule 6.14 of the Listing Requirements, the payment for the Placement Shares must be made by the placees within five (5) market days from the price-fixing date (i.e., by 30 May 2016). As the payment for the 86,671,000 Placement Shares has not been received as at today, the Board has decided to re-fix the issue price today for the 86,671,000 Placement Shares at RM0.05 each. This issue price represents a premium of approximately 24.69% to the five (5)-day volume weighted average market price of ABT Shares up to and including 27 May 2016 of RM0.0401. This announcement is dated 30 May 2016.

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Mar 2016

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Mar 2016	31 Mar 2015	31 Mar 2016	31 Mar 2015
		$$'000	$$'000	$$'000	$$'000

1	Revenue	2,943	0	9,518	0
2	Profit/(loss) before tax	-10,415	0	-28,828	0
3	Profit/(loss) for the period	-10,415	0	-28,828	0
4	Profit/(loss) attributable to ordinary equity holders of the parent	-9,272	0	-27,432	0
5	Basic earnings/(loss) per share (Subunit)	-1.07	0.00	-3.17	0.00
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.0461		0.0742

icy97

ASIA BIOENERGY TECHNOLOGIES BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?	No
Types of corporate proposal	Private Placement
Details of corporate proposal	PRIVATE PLACEMENT OF UP TO TEN PERCENT (10%) OF THE ISSUED AND PAID-UP SHARE CAPITAL OF ASIA BIOENERGY TECHNOLOGIES BERHAD ("PRIVATE PLACEMENT")
No. of shares issued under this corporate proposal	86,671,000
Issue price per share ($$)	Malaysian Ringgit (MYR)   0.0500
Par Value ($$)	Malaysian Ringgit (MYR)   0.050
Latest issued and paid up share capital after the above corporate proposal in the following
Units	953,382,600
Currency	Malaysian Ringgit (MYR) 47,669,130.000
Listing Date	01 Jun 2016

icy97

仍看好前景．亚洲生物能源续投资油气下游业

（吉隆坡24日讯）亚洲生物能源（ASIABIO，0150，创业板贸服组）相信油气领域将好转，因此不放弃投资在油气下游领域的计划。

亚洲生物能源执行董事陈石义在股东大会后表示，该公司瞄准的是可以提供附加价值和服务的油气公司。

他相信大马油气业依然拥有作为，并会好转。

他说，该公司目前有一些计划在进行，惟尚不能公布详情。

他也指出，该公司目前没有投资在其他领域的计划。

陈石义说，亚洲生物能源在2016财政年面对亏损，主要是因为全球经济不明朗，导致投资情绪低迷，拖累公司所投资的上市公司股价下滑。

亚洲生物能源2016财政年净亏损由前期的377万4674令吉扩大至2743万1801令吉；营业额则由前期的5323万2689令吉缩减至951万8186令吉。

该公司也更换财政年结账日期至3月31日。

投资对象基本面强劲

另一位执行董事梁国强说，该公司所投资的上市公司基本面都很强劲。

“威能（VSOLAR，0066，创业板科技组）专注在太阳能项目、富斯科（FOCUS，0116，创业板科技组）业务则涉及餐饮业和NETX控股（NETX，0020，创业板科技组）则涉及支付系统。”

他说，公司目前所要做的事情是采取积极措施打造公司。

他说，在近年，该公司改变投资策略，投资在上市公司，以便可以了解所投资的公司运作。

梁国强目前是威能和富斯科的执行董事，陈石义则是NETX的执行董事。

陈石义认为，该公司的投资属于长期性投资，因此，需时至少3至4年的时间始能看到成功。

另外，提到与威能合作在太阳能发电站种植农作物一事，梁国强表示该站建设已完成，预计将于今年9月运作。

他说，亚洲生物能源希望通过微生物协助该站取得更有效的增长。

他说，该公司的研发部门在研究可种植在该站的农作物。

文章来源：
星洲日报‧财经‧2016.08.24

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Jun 2016

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Jun 2016	30 Jun 2015	30 Jun 2016	30 Jun 2015
		$$'000	$$'000	$$'000	$$'000

1	Revenue	1,507	6,474	1,507	6,474
2	Profit/(loss) before tax	-7,689	-10,270	-7,689	-10,270
3	Profit/(loss) for the period	-7,689	-10,270	-7,689	-10,270
4	Profit/(loss) attributable to ordinary equity holders of the parent	-7,683	-10,182	-7,683	-10,182
5	Basic earnings/(loss) per share (Subunit)	-0.86	-1.17	-0.86	-1.17
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.0384		0.0461

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" OR "THE COMPANY") - SUBSCRIPTION OF RIGHTS AND EXCESS SHARES OF AT SYSTEMATIZATION BERHAD ("ATS") PURSUANT TO THE RENOUNCEABLE RIGHTS ISSUE TOGETHER WITH FREE WARRANTS
1.         INTRODUCTION The Board of Directors of Asia Bioenergy Technologies Berhad (“ABT” or “the Company”) wishes to announce that its wholly-owned subsidiary, Asiabio Capital Sdn. Bhd. (“ACSB”) has on 25 October 2016 subscribed to 39,369,100 rights and 84,093,500 excess rights shares of par value RM0.03 each of AT Systematization Berhad (“ATS”) at an issue price of RM0.06 each (“Rights Shares”) together with 61,731,300 free Warrants B of ATS for a total cash considerationof RM7,407,756 (“Consideration”) pursuant to the Rights Issue with Warrants B of ATS (“Subscription”). Also, pursuant to Rule 9.19(26) of the ACE Market Listing Requirements (“ACE LR”) of Bursa Malaysia Securities Berhad (“Bursa Securities”), the Company wishes to announce that subsequent to the Subscription, ACSB has effectively increased its shareholding in ATS from 9.09% to 18.80% based on ATS’s enlarged issued and paid-up share capital after completion of the Rights Issue with Warrants B of ATS. 2.         DETAILS OF THE SUBSCRIPTION 2.1       Information on ATS ATS is a public listed company listed on ACE Market of Bursa Securities with an authorised share capital of RM100,000,000, divided into 3,333,333,333 ordinary shares of RM0.03 each (“Shares”). Its enlarged issued and paid-up share capital after the completion of the Rights Issue with Warrants B of ATS or Subscription is RM25,983,638 comprising of 866,121,260 Shares. ATS, through its subsidiaries, designs and manufactures industrial automation systems and machinery, fabricates industrial and engineering parts, as well owns interests in dormant companies. ATS Group is also involved in the sale and delivery of renewable energy.  It has an existing and operational solar photovoltaic (“Solar PV”) plant with capacity of 425 kilowatts (“kW”) on an existing factory in Bayan Lepas, Penang. On 1 March 2016, ATS’s wholly-owned subsidiary, AT Precision Tooling Sdn Bhd (“ATP”) has secured a feed-in approval for renewable energy quota allocation from the Sustainable Energy Development Authority Malaysia (“SEDA”) to construct a solar photovoltaic installation under the Feed-in Tariff Programme to supply renewable energy with capacity of 300kW. On 11 May 2016, ATP signed a Renewable Energy Power Purchase Agreement (“REPPA”) with Tenaga Nasional Berhad (“TNB”) for the sale and delivery of renewable energy by ATP to TNB for a concession period of 21 years commencing from the first date of supply of renewable energy to TNB. Arising from the above, ATP intends to construct another 300kW Solar PV Plant on one (1) of its two (2) existing factories located in Bayan Lepas, Penang. The total construction cost for the 300kW Plant is estimated to be RM3 million. The construction is expected to commence immediately upon completion of the Rights Issue with Warrants B of ATS and is expected to be completed within six (6) months from commencement of construction. On 24 March 2016, Fong’s & AT venture Sdn Bhd (“FATV”), a 75%-owned subsidiary of ATP, signed a purchase agreement (“BPA”) with Fong’s Engineering & Manufacturing Pte Ltd (“FEM”), one of ATP’s major customer and a 25% shareholder of FATV. Under the BPA, FATV shall manufacture, supply and deliver high precision machine components to one of FEM’s major customer, namely Rieter Group. 2.2       Information of ACSB ACSB, which was incorporated on 28 November 2008, has an authorised share capital of RM10,000,000, divided into 10,000,000 ordinary shares of RM1.00 each, of which 6,021,000 ordinary shares are issued and fully paid up. ACSB’s principal activity is in investing and trading of quoted securities and related activities. 2.3       Basis of Arriving At the Consideration The Consideration was determined after the fixing of the issue price of RM0.06 per Rights Share on 5 September 2016 which represents a premium of approximately RM0.0102 or 20.48% from the theoretical ex-rights price of RM0.0498 per ATS Shares, calculated based on the five (5)-day weighted average market price of ATS shares up to and including 2 September 2016, being the last trading day before the price-fixing date of the Rights Shares and Warrants B on 5 September 2016 of RM0.0496 per share. 2.4       Funding for the Subscription The Consideration paid for the Subscription was funded entirely from internally generated funds of the Company. 2.5       Liabilities to be Assumed There are no liabilities, including contingent liabilities and guarantees to be assumed by ABT, arising from the Subscription. 3.         RATIONALE ABT has investment interest in the business of renewable energy and this is currently being pursued by ATS which has approvals from  SEDA to supply renewable solar energy to TNB with its units securing the Feed-in Approval (FiA) from SEDA to supply up to 725 kW of renewable energy. The details of the Solar PV Plants being operated and pursued by ATS are provided below:- Details Existing 425kW Plant Proposed 300kW Plant Capacity 425kW 300kW Size 2,760 sq meters 2,711 sq meters Location Plot 82 Lintang Bayan Lepas Industrial Park 11900 Bayan Lepas Penang Plot 49 Hilir Sungai Keluang 2 Phase IV Bayan Lepas Industrial Park 11900 Bayan Lepas Penang Current Status Operational To be constructed Current use of building Manufacturing plant for industrial automation systems Manufacturing plant for fabrication of industrial and engineering parts Date of REPPA 17 November 2015 11 May 2016 Concession period 21 years 21 years Total estimated energy generation per annum 616MWh 414MWh Total estimated value of energy generated per annum RM0.54 million RM0.33 million 4.         PROSPECTS ABT Group believes that solar power is set to become one of the most rapidly growing renewable energy sources in the world and its outlook will remain favorable in the long term future due to increasing demand for renewable energy which is further endorsed by the Malaysian government with the setting of a target for renewable energy to achieve 5.5% of Malaysia’s total electricity mix to be generated by 2015. By 2020, the target is for renewable energy to comprise 11% or 2,080MW of overall electricity generation in the country. 5.         RISK FACTORS Save for the normal business and global economic risk, the Board of Directors of ABT is not aware of any other risk factors which may arise as a result of the Subscription. 6.         FINANCIAL EFFECTS OF THE SUBSCRIPTION The Subscription is not expected to have any material effect on the earnings per share, net assets per share, gearing, share capital and the substantial shareholders' shareholdings of ABT Group for the financial year ending 31 March 2017. 7.         APPROVALS REQUIRED The Subscription is not subject to any approvals being obtained by ABT. 8.         EXPECTED TIMEFRAME The Subscription is completed upon the quotation and listing of the Rights Shares on Bursa Securities on 25 October 2016. 9.         DIRECTORS’ AND MAJOR SHAREHOLDERS’ INTEREST None of the Directors and/or major shareholders and/or any person connected to the Directors and/or major shareholders of ABT has any interest, either direct or indirect in the Subscription. 10.       DIRECTORS’ STATEMENT The Board of Directors of ABT having considered all aspects of the Subscription is of the opinion that the Subscription is in the best interest of the ABT Group. 11.       PERCENTAGE RATIO The highest percentage ratio applicable to the Subscription pursuant to Rule 10.02 of the ACE LR of Bursa Securities is 18.53% based on the latest audited financial statements of ABT as at 31 March 2016. This announcement is dated 25 October 2016.

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" OR "THE COMPANY") - SUBSCRIPTION OF RIGHTS AND EXCESS SHARES OF AT SYSTEMATIZATION BERHAD ("ATS") PURSUANT TO THE RENOUNCEABLE RIGHTS ISSUE TOGETHER WITH FREE WARRANTS
With reference to the announcement made on 25 October 2016 on the Subscription (as defined in the previous announcement), the Board of Directors of Asia Bioenergy Technologies Berhad ("ABT" or "the Company") wishes to clarify that the computation of the highest percentage ratio applicable to the Subscription pursuant to Rule 10.02 of the ACE Market Listing Requirements of Bursa Malaysia Securities Berhad (“ACE LR of Bursa Securities”) should only take into account the number of excess shares subscribed by Asiabio Capital Sdn. Bhd. (“ACSB”), a wholly-owned subsidiary of ABT, and should exclude ACSB’s entitlement to the rights shares. Hence, the current percentage ratio should be 12.62% instead of 18.53%, as stated in the announcement dated 25 October 2016. The percentage ratio as stated in the announcement dated 25 October 2016 includes ACSB’s entitlement to the rights shares. This announcement is dated 27 October 2016.

icy97

ASIA BIOENERGY TECHNOLOGIES BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?	No
Types of corporate proposal	ESOS
Details of corporate proposal	Share Issuance Scheme
No. of shares issued under this corporate proposal	80,000,000
Issue price per share ($$)	Malaysian Ringgit (MYR)   0.0500
Par Value ($$)	Malaysian Ringgit (MYR)   0.050
Latest issued and paid up share capital after the above corporate proposal in the following
Units	1,033,382,600
Currency	Malaysian Ringgit (MYR) 51,669,130.000
Listing Date	31 Oct 2016

icy97

携手潜在油气合约
亚洲生化受委优先承包商

2016年11月2日
（吉隆坡1日讯）亚洲生化（ASIABIO，0150，创业板）旗下Asiabio石油与Coral Alliance签约，委任Asiabio石油作为潜在合约的优先和独立承包商。

根据文告，Asiabio石油与Coral Alliance签署合作及委任优先承包商协议，以携手负责和完成有可能颁发给Coral Alliance的合约，总值高达3000万令吉。

Coral Alliance是拥有国家石油（Petronas）执照的公司，以供应产品和服务给勘探与油气公司，国油勘探（Petronas Carigali）是其中一名客户。

至于合作与分包项目的范围，则将根据Coral Alliance的采购和服务订单。

亚洲生化相信，上述合约将在合约期间为公司贡献净利。【e南洋】

Type	Announcement
Subject	OTHERS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" OR "THE COMPANY")- COLLABORATION AGREEMENT AND APPOINTMENT OF PREFERRED CONTRACTOR BETWEEN ASIABIO PETROLEUM SDN. BHD. AND CORAL ALLIANCE SDN. BHD.
1.0            INTRODUCTION The Board of Directors of ABT is pleased to announce that its wholly-owned subsidiary, Asiabio Petroleum Sdn. Bhd. (“ABP”) has on 1 November 2016 entered into a Collaboration Agreement and Appointment of Preferred Contractor (“Agreement”) with Coral Alliance Sdn. Bhd. (“CORAL”) to collaborate in undertaking and completing work and/or services with a value of up to RM30 million which may be awarded to CORAL from time to time. ABP and CORAL also agree that ABP shall be the preferred and independent contractor for the project which may be awarded by CORAL to ABP from time to time (“Project”) for the duration of the Agreement. 2.0            INFORMATION ON CORAL AND ABP 2.1          CORAL CORAL, a company incorporated in Malaysia under the Companies Act 1965 is principally involved in the business of providing integrated brownfield services, project management, multidiscipline and engineering services to onshore and offshore oil and gas industries and the provision of topside structural maintenance services. CORAL is also a company licensed by Petroliam Nasional Berhad to supply products and services to exploration and oil/gas companies. They have secured several engineering, maintenance and supply contracts with major oil and gas companies in Malaysia. One of CORAL’s notable clients is Petronas Carigali Sdn Bhd. CORAL and ABP shall, hereinafter be collectively referred to as the “Parties” or individually as the “Party” as the case may be. 2.2          ABP ABP is a dormant company incorporated in Malaysia on 10 October 2014 under the Companies Act 1965 and is a wholly-owned subsidiary company of ABT. ABP will be principally involved in the business of providing engineering and maintenance services specifically for the oil and gas sector. ABP has an authorised share capital of RM400,000.00 and issued and fully paid up share capital of RM2.00 comprising 2 ordinary shares of RM1.00 each. 3.0             SALIENT TERMS OF THE AGREEMENT 3.1          Scope The scope of collaboration and the subcontract work shall be as per CORAL’s purchase/service orders (for the mechanical maintenance services, supply of materials and consumables such as pumps, valves and etc. and manpower), work pack and any other supporting documents which may be presented and accepted prior to the Project being awarded to ABP. In engaging ABP as a contractor for any scope of work required, CORAL shall notify ABP seven (7) working days in advance of the work requirements which CORAL has authorized ABP to undertake by way of purchase orders or service orders (“Work”), detailing the items, quantity and duration. 3.2          Value The work and/or services required under the Agreement will carry a value of up to RM30 million. 3.3          Duration The Agreement shall continue in full force and effect from 1 November 2016 until 31 October 2017 unless terminated earlier in accordance to the terms of the Agreement, and may be extended for a further period up to 31 October 2018 at the mutual agreement of both Parties. 4.0            FINANCIAL EFFECTS This Agreement will not have any material impact on the issued and paid-up capital of the Group and the earnings and net assets of the Group for financial year ending 31 March 2017 but is expected to contribute positively to the earnings of the ABT Group for the duration of the Agreement, in the event that CORAL awards any contracts to ABP during the tenure of the Agreement. 5.0            STATEMENT BY DIRECTORS The Directors are of the opinion that this Agreement is in the best interest of the Group after considering, amongst others, the potential financial contribution to the earnings of the Group. 6.0            APPROVAL REQUIRED This Agreement does not require approval from any authority or shareholders. 7.0            DIRECTORS AND MAJOR SHAREHOLDERS’ INTEREST None of the Directors and/or major shareholders of the Company and/or persons connected to them, has any interest, direct or indirect in this Agreement. As and when CORAL awards any Project to ABP pursuant to the Agreement, an announcement will be made pursuant to the Listing Requirements. This announcement is dated 1 November 2016.

icy97

Type	Reply to Query
Reply to Bursa Malaysia's Query Letter - Reference ID	IQL-02112016-00004
Subject	COLLABORATION AGREEMENT AND APPOINTMENT OF PREFERRED CONTRACTOR BETWEEN ASIABIO PETROLEUM SDN BHD ("ABP") AND CORAL ALLIANCE SDN BHD ("CORAL") ("AGREEMENT")
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" or "the COMPANY")- COLLABORATION AGREEMENT AND APPOINTMENT OF PREFERRED CONTRACTOR BETWEEN ASIABIO PETROLEUM SDN BHD (ABP) AND CORAL ALLIANCE SDN BHD ("CORAL")
Query Letter Contents	We refer to your Company’s announcement dated 1 November 2016, in respect of the aforesaid matter. In this connection, kindly furnish Bursa Securities with the following additional information for public release:- 1.        Whether ABP has the requisite expertise, experience and manpower to carry out its intended principal activity.  If yes, to provide details thereof.  If no, to explain how ABP intends to acquire this experience, expertise and manpower. 2.        The eventual issued and paid-up capital of ABP.
Reference is made to the announcement dated 1 November 2016 and query letter from Bursa Malaysia Berhad dated 2 November 2016 (Ref.: IQL-02112016-00004). Please refer to the attachment for further clarification on the Collaboration Agreement with Coral Alliance Sdn. Bhd. This announcement is dated 3 November 2016.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5250765

Attachments ABT - Reply to Query on Collaboration Agreement - 03.11.2016.pdf

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Sep 2016

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Sep 2016	30 Sep 2015	30 Sep 2016	30 Sep 2015
		$$'000	$$'000	$$'000	$$'000

1	Revenue	1,087	10	2,594	6,484
2	Profit/(loss) before tax	1,803	-15,219	-5,886	25,489
3	Profit/(loss) for the period	1,803	-15,219	-5,886	-25,489
4	Profit/(loss) attributable to ordinary equity holders of the parent	1,808	-15,134	-5,875	-25,316
5	Basic earnings/(loss) per share (Subunit)	0.20	-1.75	-0.64	-2.92
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.0403		0.0461

icy97

ASIA BIOENERGY TECHNOLOGIES BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?	No
Types of corporate proposal	ESOS
Details of corporate proposal	Share Issuance Scheme
No. of shares issued under this corporate proposal	40,000,000
Issue price per share ($$)	Malaysian Ringgit (MYR)   0.0500
Par Value ($$)	Malaysian Ringgit (MYR)   0.050
Latest issued and paid up share capital after the above corporate proposal in the following
Units	1,073,382,600
Currency	Malaysian Ringgit (MYR) 53,669,130.000
Listing Date	01 Dec 2016

icy97

“进场好时机”
亚洲生化看好油气领域

2016年11月24日
（吉隆坡23日）原油价格下跌让许多业者对油气领域望而却步，但亚洲生化（ASIABIO，0150，创业板）却认为，现在是进入该领域的好时机。

亚洲生化已透过旗下Asiabio石油与Coral Alliance签约，后者将委任Asiabio石油作为潜在合约的优先和独立承包商，进行维修与保养业务。

油市复苏将获益

Coral Alliance是拥有国家石油（Petronas）执照的公司，以供应产品和服务给勘探与油气公司，国油勘探（Petronas Carigali）是其中一名客户。

亚洲生化执行董事陈石义日前对媒体指出，任何往下跌的东西，必然会回升。

“我会将亚洲生化定位在油气领域，以便在油气市场复苏时获益。”

“而且，我建议的油气领域维修与保养业务，并没有因原油价格下跌而严重受创，相反的这类服务非常具有韧力。”

“我们将集中寻找年限介于20至30年的油气平台，因为它们需要更换零件。”

此外，陈石义补充，纵然油气市场不好，但是耗资600亿令吉的石油化工综合发展（RAPID）项目都没有中断过。

“我相信公司可趁这时机，搭上油气领域复苏的涨潮。”【e南洋】

icy97

偕Rangkain Iltizam
亚洲生化发展再生能源

2016年12月21日
（吉隆坡20日讯）亚洲生化（ASIABIO，0150，创业板）与Rangkain Iltizam私人有限公司（RISB）签署一项意向备忘录，进行商业合作，以便进一步发展后者的再生能源项目。

亚洲生化向马交所报备，两家公司的合作范围，将围绕在数项发展项目，包括生物沼气（Biogas）发电设备、有机肥料生产设备、有机饲料生产设备，以及高粱（Sorghum）专利或承包农业耕作。

RISB是一家涉及再生能源、有机肥料和净水生产的公司。

拟购配售股

此外，RISB想要通过配售10万股筹集高达600万令吉，而亚洲生化正在考虑认购该批配售的股票，或积极地协助RISB寻找投资者认购该批股票，或为上述发展项目筹资。

在签署股票认购协议前，亚洲生化将会对RISB进行财务和技术精密审核和审计工作。【e南洋】

Type	Announcement
Subject	MEMORANDUM OF UNDERSTANDING
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" or "the Company")- MEMORANDUM OF INTENT WITH RANGKAIN ILTIZAM SDN. BHD.
1.0       INTRODUCTION The Board of Directors of ABT is pleased to announce that the Company will enter into a Memorandum of Intent (“MOI”) with Rangkain Iltizam Sdn. Bhd. (“RISB”) on 19 December 2016 to work together to extend the basis for commercial collaboration and co-operative exchanges between the Company and RISB.      2.0       INFORMATION ON RISB RISB, a private limited company incorporated in Malaysia on 23 July 1997 under the Companies Act 1965 and having its business address at 2-6-6, Menara KLH Business Centre, No. 2, Jalan Ipoh, 51200 Kuala Lumpur, is principally involved in the business of renewable energy, organic fertilizer and clean water production. RISB and ABT shall, hereinafter be collectively referred to as the “Parties” or individually as the “Party” as the case may be.                3.0       SALIENT TERMS OF THE MOI                      3.1       General area of cooperation and collaboration                The scope of cooperation and collaboration shall be carried out through such activities of Project Development in the following areas:-             (a)        Biogas Energy Generation facilities;             (b)        Organic Fertilizer production facilities;             (c)        Organic Animal Feed production facilities; and             (d)        Proprietary or contract farming of Sorghum.                     The term of such mutual cooperation and necessary funding of each programme and activity enumerated above are not exhaustive and the parties may agree to include such             other programmes or activities as may be necessary and identified later which shall be mutually discussed and agreed upon in writing by both parties prior to the initiation of               the particular programme or activity and such shall be negotiated as required. 3.2       General investment & financing terms             RISB is desirous to raise up to Ringgit Malaysia Six Million (RM6,000,000.00) only via the placement of 100,000 shares in RISB (“Placement Shares”).             ABT is considering to subscribe to the Placement Shares and/or actively assisting RISB in sourcing for subscribers to the Placement Shares or raising capital for the Project Development stated in item 3.1 above.             ABT will be entitled to conduct and carry out a financial and technical due diligence review and investigation at its own cost on RISB, it financial information and its technical representations prior to any execution of a Definitive Share Subscription Agreement. 3.3       Duration and termination             The MOI shall commence on the date of execution and shall remain in force for a duration of one (1) year and shall continue to remain in force by a written agreement between the Parties.             Each Party may terminate the MOI by giving three (3) months written notice in advance to the other Party. Upon termination, each Party shall return any documents retained by the same to its original owner accordingly. 3.4       Relationship between the parties            Nothing contained in the MOI shall be construed so as to constitute a joint venture partnership or formal business organisation or any kind between the Parties or so to constitute either Party as the agent of the other. 3.5       Intellectual Property Rights            The intellectual property rights in respect of any technological development, and any products and services development, carried out:-            (i)         jointly by the Parties of the new findings or research results obtained through  the joint effort of the Parties, shall be jointly owned by the Parties in accordance with the terms to be mutually agreed upon; and            (ii)        solely and separately by the Party of the research results obtained through the sole and separate effort of the Party, shall be solely owned  by the Party concerned as its own Proprietary Intellectual Property Rights. 4.0       RATIONALE The objective of the MOI is to work together to extend the basis for commercial collaboration and co-operative exchanges between the Company and RISB, for the further development of RISB’s Renewable Energy Projects. 5.0       EFFECT OF THE MOI The MOI is not expected to have any effect on the revenue, net assets, share capital and shareholdings structure of ABT. 6.0       DIRECTORS AND MAJOR SHAREHOLDERS’ INTEREST None of the Directors and/or major shareholders of the Company and/or persons connected to them, has any interest, direct or indirect in this MOI. 7.0       DIRECTOR’S STATEMENT The Board of Directors of ABT, having considered the rationale and terms of the MOI, is of the opinion that the MOI is in the best interest of the Company. 8.0       DOCUMENTS FOR INSPECTION A copy of the MOI is available for inspection at the registered office of the Company located at 10th Floor, Menara Hap Seng, No. 1 & 3, Jalan P. Ramlee, 50250 Kuala Lumpur during normal business hours on Mondays to Fridays (except Saturdays, Sundays and Public Holidays) for a period of three (3) months from the date of this announcement. This announcement is dated 19 December 2016.

icy97

亚洲生物能源联营化学原料公司

（吉隆坡17日讯）亚洲生物能源（ASIABIO,0150,创业板贸服组）与Acme化学有限公司及Sejahtera Bumisama有限公司签署意向备忘录，共同在民都鲁发展一间供应化学原料给跨国油气企业的公司。

该公司发布文告中表示，该意向书的期限为其一年，其总投资金额不会超过600万令吉。

文章来源：
星洲日报／财经‧2017.02.17

Type	Announcement
Subject	MEMORANDUM OF UNDERSTANDING
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD (ABT or the Company)- MEMORANDUM OF INTENT BETWEEN ASIABIO PETROLEUM SDN. BHD., A WHOLLY OWNED SUBSIDIARY OF ABT AND ACME CHEMICALS (MALAYSIA) SDN. BHD. AND SEJAHTERA BUMISAMA SDN. BHD.
Please refer to the attachment below.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5338189

Attachments ABT - Memorandum of Intent - 15.02.2017.pdf

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Dec 2016

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Dec 2016	31 Dec 2015	31 Dec 2016	31 Dec 2015
		$$'000	$$'000	$$'000	$$'000

1	Revenue	881	91	3,475	6,575
2	Profit/(loss) before tax	-7,933	7,076	-13,819	-18,413
3	Profit/(loss) for the period	-7,933	7,076	-13,819	-18,413
4	Profit/(loss) attributable to ordinary equity holders of the parent	-7,926	7,156	-13,801	-18,160
5	Basic earnings/(loss) per share (Subunit)	-0.83	0.83	-1.44	-2.10
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.0391		0.0461

icy97

亚洲生化亏67万
沽清Carimin石油

2017年3月16日
（吉隆坡15日讯）亚洲生化（ASIABIO，0150，创业板）沽清所持的Carimin石油（CARIMIN，5257，主板贸易服务股）股权，蒙亏67万令吉。

亚洲生化昨日向交易所报备，独资子公司Asiabio Capital私人有限公司过去12个月，通过公开市场，脱售Carimin石油共688万7800股。

脱售所得268万4630.66令吉，将汇入公司的科技孵化器基金，并用作未来3年的投资。

报备文件说，这批股权是在2014年11月13日至2015年8月13日间购入，总投资额335万令吉。

脱售带来的亏损，有29万令吉已反映在2016财年，而本财年再入账38万令吉，或相等于每股约0.044仙。

Carimin石油2014年11月上市时，发售价1.10令吉，至今已蒸发了71%。【e南洋】

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" or "the Company")- DISPOSAL OF SHARES IN CARIMIN PETROLEUM BERHAD
Please refer to the attachment below.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5365809

Attachments ABT - Chapter 10 (Disposal of Carimin shares) - 14.03.2017.pdf